AZTA Azenta Inc.

Azenta, Inc. provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide. The company operates in two segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated ultra-cold storage systems and consumables, including racks, tubes, caps, plates, and foils; instruments, such as labeling, bar coding, capping, de-capping, auditing, sealing, peeling, piercing tubes, and plates. The Life Sciences Services segment offers genomic services and sample repository solutions, including on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting; and informatics provides sample intelligence software solutions, which support laboratory workflow scheduling for life science tools and instrument work cells, sample, inventory and logistics, environmental and temperature monitoring, clinical trial and consent management, and planning, data management, virtualization and visualization of sample collections. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

Recent Analyst Ratings for Azenta Inc.

Date	Price Target	Rating	Analyst
12/18/2024	$50.00 → $60.00	Equal-Weight → Overweight	Stephens
4/4/2024	$64.00	Hold	Jefferies
2/1/2024	$61.00 → $79.00	Buy	B. Riley Securities
7/19/2023		Mkt Perform	Raymond James
5/10/2023		Overweight → Sector Weight	KeyBanc Capital Markets
2/9/2023	$65.00 → $60.00	Overweight → Equal-Weight	Stephens
1/3/2023	$60.00 → $62.00	Outperform → In-line	Evercore ISI
3/31/2022	$106.00	Buy	B. Riley Securities
3/21/2022	$100.00	Outperform	Evercore ISI
2/9/2022	$155.00 → $115.00	Buy	Needham

See more ratings

Azenta Inc.

Recent Analyst Ratings for Azenta Inc.

Azenta Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

President and CEO Marotta John was granted 1,000 units of Common, increasing direct ownership by 0.94% to 107,296 units (SEC Form 4)

Amendment: President and CEO Marotta John was granted 5,434 units of Common, increasing direct ownership by 5% to 106,296 units (SEC Form 4)

Director Malus Alan J was granted 12,000 units of Common, increasing direct ownership by 238% to 17,035 units (SEC Form 4)

SVP, Gen Counsel & Secretary Starr Ephraim was granted 37,779 units of Common (SEC Form 4)

SEC Form 3 filed by new insider Starr Ephraim

Director Cornog William L was granted 7,000 units of Common (SEC Form 4)

EVP, CFO and Treasurer Lin Lawrence Y. was granted 6,000 units of Common, increasing direct ownership by 16% to 43,513 units (SEC Form 4)

President and CEO Marotta John was granted 5,434 units of Common, increasing direct ownership by 7% to 106,296 units (SEC Form 4)

EVP, CFO and Treasurer Lin Lawrence Y. was granted 2,200 units of Common, increasing direct ownership by 6% to 37,513 units (SEC Form 4)

Director Koffey Quentin was granted 4,040 shares, increasing direct ownership by 406% to 5,035 units (SEC Form 4)